Who owns BRIDGEBIO PHARMA INC?
- CUSIP Number: 10806xab8
Tip: Access positions for across all investors
Analyze quarterly positions in Bridgebio Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Bridgebio Pharma stock
Who bought or sold BRIDGEBIO PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Braidwell | 136M | $146M | 19% | Mar 2024 |
|
| Graham Capital Management | 73M | $79M | 0% | Mar 2024 |
|
| Wolverine Asset Management | 41M | $45M | 196% | Mar 2024 |
|
| Aristeia Capital | 35M | $38M | -35% | Mar 2024 |
|
| Weiss Asset Management LP[1 | 29M | $31M | 314% | Mar 2024 |
|
| D. E. Shaw & Co | 21M | $23M | 0% | Mar 2024 |
|
| 683 Capital Management | 17M | $19M | 17% | Mar 2024 |
|
| Lazard Asset Management | 16M | $20M | 34983% | Dec 2023 |
|
| Wells Fargo & Company | 15M | $16M | -13% | Mar 2024 |
|
| Point72 Asset Management | 15M | $16M | -19% | Mar 2024 |
|
| Calamos Advisors | 10M | $11M | 0% | Mar 2024 |
|
| Ubs Global Asset Management Americas | 7.0M | $7.5M | 0% | Mar 2024 |
|
| Lord, Abbett & Co | 5.5M | $5.9M | -59% | Mar 2024 |
|
| SSI Investment Management | 4.8M | $5.7M | 100% | Dec 2023 |
|
| BlackRock | 4.2M | $4.5M | 14% | Mar 2024 |
|
| Franklin Resources | 3.4M | $3.7M | 100% | Mar 2024 |
|
| CSS | 3.2M | $3.4M | -14% | Mar 2024 |
|
| RWC Asset Management | 2.1M | $2.3M | 100% | Mar 2024 |
|
| Man Group | 2.0M | $2.2M | 0% | Mar 2024 |
|
| Royal Bank of Canada | 1.7M | $1.8M | -1% | Mar 2024 |
|
| Axa | 1.5M | $1.6M | 100% | Mar 2024 |
|
| Shenkman Capital Management | 1.1M | $1.2B | 52% | Mar 2024 |
|
| Bank of New York Mellon | 500k | $538k | 0% | Mar 2024 |
|
| Palisade Capital Management | 414k | $445k | 0% | Mar 2024 |
|
| Credit Suisse | 300k | $370k | 0% | Mar 2024 |
|
| Central Pacific Bank - Trust Division | 247k | $262k | 100% | Mar 2024 |
|
| Russell Investments | 160k | $172k | -14% | Mar 2024 |
|
| KBC Group NV | 100k | $108k | 0% | Mar 2024 |
|
| First Hawaiian Bank | 95k | $102k | 0% | Mar 2024 |
|
| Fox Hill Wealth Management | 74k | $79k | 4% | Mar 2024 |
|
| Citadel Advisors | 24k | $26k | 100% | Mar 2024 |
|
| Stonegate Investment Group | 12k | $13k | 0% | Mar 2024 |
|
| Context Capital Management | 110.00 | $118k | -100% | Mar 2024 |
|
Who sold out of Bridgebio Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Linden Advisors | Sep 2023 | 42M | $41B |
| MacKay Shields | Dec 2023 | 14M | $18M |
| Castle Creek Arbitrage | Sep 2023 | 10M | $9.6M |
| Morgan Stanley | Sep 2023 | 6.5M | $6.3M |
| Jpmorgan Chase & Co | Dec 2023 | 2.8M | $3.4M |
| Highbridge Capital Management | Dec 2023 | 2.5M | $3.0B |
| New York State Common Retirement Fund | Dec 2023 | 2.1M | $2.5M |
| Aviva | Dec 2023 | 1.0M | $1.2M |
| Sei Investments | Sep 2023 | 115k | $110k |
| Citigroup | Dec 2023 | 53k | $64k |
| Aurum Wealth Management Group | Sep 2023 | 11k | $11k |
| SG Americas Securities | Dec 2023 | 9.0k | $1.1M |